BioNexus Gene Lab Corp. (BGLC) vs E-Power Inc. Class A (EPOW)

A side-by-side comparison of BioNexus Gene Lab Corp. and E-Power Inc. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGLC vs EPOW

growth of $100 · dividends reinvested · last 6y
BGLC -99.5% (-58.2%/yr)EPOW -97.2% (-44.8%/yr)EPOW compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$1$3
BGLC EPOW

BGLC vs EPOW: by the numbers

  • •EPOW is the larger company ($4M vs $3M market cap).
  • •Both run net losses; EPOW's is the smaller (-35.84% vs -82.36% net margin).
  • •EPOW grew revenue faster over the past five years (14.90% vs -31.68% CAGR).

Metrics side by side

Valuation

MetricBGLCEPOW
P/S ratio1.01N/A
P/B ratio0.40N/A

Profitability

MetricBGLCEPOW
Gross margin11.64%-12.60%
Operating margin-42.54%-34.53%
Net margin-82.36%-35.84%
ROE-33.11%N/A
ROIC-32.71%-16.56%

Growth (annualized)

MetricBGLCEPOW
Revenue CAGR (5Y)-31.68%14.90%
Total return CAGR (5Y)-61.00%-40.49%

Frequently asked

Which has grown faster, BGLC or EPOW?
Over the past five years, EPOW grew revenue faster — BGLC at a -31.68% CAGR versus EPOW at 14.90%.
How have BGLC and EPOW total returns compared?
Over the past 5 years, BGLC delivered -61.00% and EPOW delivered -40.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.